Proficon Medisol Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.10 M
- Company Age 20 Year, 3 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.12 M
- Revenue Growth 24.41%
- Profit Growth -61.79%
- Ebitda -1394.49%
- Net Worth 20.74%
- Total Assets 16.37%
About Proficon Medisol
Proficon Medisol Private Limited (PMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 21 February 2005 and has a history of 20 years. Its registered office is in Delhi, India.
The Corporate was formerly known as Sps Medipool Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.12 M.
Sapna Trehan, Ajitesh Trehan, and Sanjay Trehan serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51397DL2005PTC133187
- Company No.
133187
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Feb 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Proficon Medisol?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajitesh Trehan  | Director | 17-Mar-2017 | Current |
| Sapna Trehan | Director | 21-Feb-2005 | Current |
| Sanjay Trehan | Director | 17-Mar-2017 | Current |
Financial Performance of Proficon Medisol.
Proficon Medisol Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 24.41% increase. The company also saw a substantial fall in profitability, with a 61.79% decrease in profit. The company's net worth Soared by an impressive increase of 20.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Proficon Medisol?
Unlock access to Proficon Medisol's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹7.12 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.71 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Dec 2020 | Hdfc Bank Limited | ₹7.12 M | Open |
How Many Employees Work at Proficon Medisol?
Proficon Medisol has a workforce of 4 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Proficon Medisol, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Proficon Medisol's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
